Bayer projects up to 10.1 bln eur in adj earnings this year
Published on March 4, 2026.
German pharmaceuticals and crop protection group, Bayer, is aiming for adjusted earnings of up to €10.1 billion ($11.7 billion) this year, excluding the effect of currency swings. The company expects 2026 EBITDA to be between 9.6 and 10.9 billion euros.
Read Original Article